Calvert Investment Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Calvert Investment Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,843	Closed	-$491K	–	722
2015 Q1	$491K	Buy	2,843 +454	+19%	+$66.6K	0.03%	360
2014 Q4	$275K	Buy	2,389 +51	+2%	+$6.18K	0.02%	494
2014 Q3	$365K	Buy	+2,338	New	+$339K	0.03%	391

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Calvert Investment Management's SLXP Position: Q2 2015 in Review

Calvert Investment Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,843 shares — an estimated $491K sold.

Calvert Investment Management first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $491K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Calvert Investment Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Calvert Investment Management sold 2,843 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $491K.
Calvert Investment Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
Calvert Investment Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $491K in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Calvert Investment Management's 13F filing for Q2 2015, filed 4 Aug 2015.